Acasti Pharma Inc. (ACST) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Laval, QC, Canada. The current CEO is Prashant Kohli.
ACST has IPO date of 2012-02-07, 32 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $34.17M.
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
